Home Cart 0 Sign in  
X

[ CAS No. 492-98-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 492-98-8
Chemical Structure| 492-98-8
Chemical Structure| 492-98-8
Structure of 492-98-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 492-98-8 ]

Related Doc. of [ 492-98-8 ]

Alternatived Products of [ 492-98-8 ]

Product Details of [ 492-98-8 ]

CAS No. :492-98-8 MDL No. :MFCD00047014
Formula : C6H6N4 Boiling Point : -
Linear Structure Formula :- InChI Key :AZUHIVLOSAPWDM-UHFFFAOYSA-N
M.W : 134.14 Pubchem ID :101463
Synonyms :

Calculated chemistry of [ 492-98-8 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 36.17
TPSA : 57.36 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.19 cm/s

Lipophilicity

Log Po/w (iLOGP) : -0.23
Log Po/w (XLOGP3) : -0.1
Log Po/w (WLOGP) : 0.8
Log Po/w (MLOGP) : -0.96
Log Po/w (SILICOS-IT) : 1.77
Consensus Log Po/w : 0.26

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.28
Solubility : 7.0 mg/ml ; 0.0522 mol/l
Class : Very soluble
Log S (Ali) : -0.65
Solubility : 29.9 mg/ml ; 0.223 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.56
Solubility : 0.372 mg/ml ; 0.00277 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.56

Safety of [ 492-98-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 492-98-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 492-98-8 ]
  • Downstream synthetic route of [ 492-98-8 ]

[ 492-98-8 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 131543-46-9 ]
  • [ 492-98-8 ]
YieldReaction ConditionsOperation in experiment
53.2%
Stage #1: With ammonium acetate In water at 20 - 40℃; for 3 h;
[0024] 120 ml of distilled water was added to 1,092 g (14.2 mol, 4.0 eq.) of ammonium acetate at 40[deg.] C., and 500 g of 20 wt percent aqueous glyoxal (3.45 mol) was then slowly added dropwise to the resulting slurry for three hours while vigorously stirring. Immediately after the addition was finished, the reaction mixture was neutralized with distilled water so as to adjust pH to 5-7. The produced brown colored solid was filtered, and washed alternately with 500 ml of acetone and 500 ml of distilled water several times, to obtain 82.0 g (53.2percent yield) of 2,2'-bi-1H-imidazole having a purity of not less than 97percent.
50.9%
Stage #1: With ammonium acetate In water at 20 - 40℃; for 8 h;
Stage #2: With ammonia In water
Example 1
130 ml of distilled water was added to 709 g of ammonium acetate (9.2 mol, 2.67 eq.) at 40° C., and 500 g of 20 wt percent aqueous glyoxal (3.45 mol) was then slowly added dropwise to the resulting slurry for three hours while vigorously stirring.
The resulting reaction mixture was additionally stirred for five hours at room temperature.
The reaction mixture was then neutralized with aqueous ammonia so as to adjust pH to 5-7.
The produced brown colored solid was filtered and then washed alternately with 500 ml of acetone and 500 ml of distilled water several times, to obtain 78.4 g (50.9percent yield) of 2,2'-bi-1H-imidazole having a purity of not less than 97percent.
45.8%
Stage #1: With ammonium acetate In water at 20 - 40℃; for 8 h;
Stage #2: With sodium hydroxide In water
[0021] The same amount of glyoxal as in Example was reacted with ammonium acetate in the same manner as described in Example 1. The reaction mixture was then neutralized with 5percent aqueous sodium hydroxide, instead of aqueous ammonia, to obtain 70.6 g (45.8percent yield) of the desired product.
44.6%
Stage #1: With ammonium formate In water at 50℃; for 1.5 h;
Stage #2: With ammonia In water
Example 3
130 ml of distilled water was added to 580 g (9.2 mol, 2.67 eq.) of ammonium formate at 50° C., and 500 g of 20 wt percent aqueous glyoxal (3.45 mol) was then slowly added dropwise to the resulting slurry for one and a half hours while vigorously stirring.
Immediately after the addition was finished, the reaction mixture was neutralized with aqueous ammonia so as to adjust pH to 5-7.
The produced brown colored solid was filtered, and washed alternately with 500 ml of acetone and 500 ml of distilled water several times, to obtain 68.7 g (44.6percent yield) of 2,2'-bi-1H-imidazole having a purity of not less than 97percent.
43.1%
Stage #1: With ammonium benzoate In water at 20 - 40℃; for 4 h;
Stage #2: With ammonia In water
Example 4
130 ml of distilled water was added to 959 g (6.9 mol, 2.0 eq.) of ammonium benzoate at 40° C., and 500 g of 20 wt percent aqueous glyoxal (3.45 mol) was then slowly added dropwise to the resulting slurry for three hours while vigorously stirring.
The resulting reaction mixture was then additionally stirred for one hour at room temperature.
The reaction mixture was then neutralized with aqueous ammonia so as to adjust pH to 5-7.
The produced brown colored solid was filtered, and washed alternately with 500 ml of acetone and 500 ml of distilled water several times, to obtain 66.4 g (43.1percent yield) of 2,2'-bi-1H-imidazole having a purity of not less than 97percent.

Reference: [1] Patent: US2003/199700, 2003, A1, . Location in patent: Page/Page column 2
[2] Patent: US2003/199700, 2003, A1, . Location in patent: Page/Page column 2
[3] Archiv der Pharmazie, 1986, vol. 319, # 2, p. 183 - 185
[4] Patent: US2003/199700, 2003, A1, . Location in patent: Page/Page column 2
[5] Patent: US2003/199700, 2003, A1, . Location in patent: Page/Page column 2
[6] Patent: US2003/199700, 2003, A1, . Location in patent: Page/Page column 2
[7] Organic Letters, 2004, vol. 6, # 21, p. 3845 - 3847
[8] Zeitschrift fur Anorganische und Allgemeine Chemie, 2012, vol. 638, # 9, p. 1278 - 1286
[9] Bulletin of the Chemical Society of Japan, 1995, vol. 68, # 7, p. 1753 - 1774
[10] Journal of Materials Chemistry C, 2017, vol. 5, # 14, p. 3519 - 3527
[11] Canadian Journal of Chemistry, 2009, vol. 87, # 6, p. 729 - 737
[12] Journal of Heterocyclic Chemistry, 2002, vol. 39, # 4, p. 733 - 735
[13] Organic Letters, 2018, vol. 20, # 12, p. 3613 - 3617
[14] Journal of Organic Chemistry, 1989, vol. 54, # 13, p. 3057 - 3061
[15] Australian Journal of Chemistry, 1994, vol. 47, # 4, p. 723 - 738
[16] Journal of the American Chemical Society, 2003, vol. 125, # 16, p. 4951 - 4957
[17] Journal of Fluorine Chemistry, 2009, vol. 130, # 6, p. 522 - 527
[18] Patent: WO2005/26178, 2005, A2, . Location in patent: Page/Page column 77; Sheet 31
[19] Bulletin of the Korean Chemical Society, 2012, vol. 33, # 11, p. 3645 - 3650
[20] New Journal of Chemistry, 2013, vol. 37, # 11, p. 3706 - 3715
[21] RSC Advances, 2014, vol. 4, # 44, p. 23116 - 23124
[22] Australian Journal of Chemistry, 2015, vol. 68, # 10, p. 1513 - 1517
[23] Chemistry - A European Journal, 2016, vol. 22, # 6, p. 2108 - 2113
[24] Catalysis Letters, 2016, vol. 146, # 4, p. 841 - 850
[25] European Journal of Inorganic Chemistry, 2017, vol. 2017, # 12, p. 1764 - 1771
  • 2
  • [ 93241-62-4 ]
  • [ 492-98-8 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1987, vol. 23, # 8, p. 854 - 856[2] Khimiya Geterotsiklicheskikh Soedinenii, 1987, # 8, p. 1069 - 1070
  • 3
  • [ 106536-97-4 ]
  • [ 492-98-8 ]
Reference: [1] Synthesis, 1986, # 4, p. 336 - 337
  • 4
  • [ 131543-46-9 ]
  • [ 631-61-8 ]
  • [ 492-98-8 ]
Reference: [1] New Journal of Chemistry, 2015, vol. 39, # 3, p. 1827 - 1839
[2] Justus Liebigs Annalen der Chemie, 1918, vol. 416, p. 231
[3] Justus Liebigs Annalen der Chemie, 1927, vol. 456, p. 259,269,270,271
[4] Chemistry of Heterocyclic Compounds, 2017, vol. 53, # 6-7, p. 697 - 701[5] Khim. Geterotsikl. Soedin., 2017, vol. 53, # 6-7, p. 697 - 701,5
  • 5
  • [ 131543-46-9 ]
  • [ 107-21-1 ]
  • [ 492-98-8 ]
Reference: [1] Journal of Materials Chemistry C, 2016, vol. 4, # 17, p. 3726 - 3737
  • 6
  • [ 3039-13-2 ]
  • [ 492-98-8 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1987, vol. 23, # 8, p. 854 - 856[2] Khimiya Geterotsiklicheskikh Soedinenii, 1987, # 8, p. 1069 - 1070
  • 7
  • [ 496-45-7 ]
  • [ 492-98-8 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1987, vol. 23, # 8, p. 854 - 856[2] Khimiya Geterotsiklicheskikh Soedinenii, 1987, # 8, p. 1069 - 1070
  • 8
  • [ 106536-97-4 ]
  • [ 492-98-8 ]
  • [ 106536-98-5 ]
Reference: [1] Synthesis, 1986, # 4, p. 336 - 337
  • 9
  • [ 599-01-9 ]
  • [ 492-98-8 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1918, vol. 416, p. 231
[2] Journal of the Chemical Society, 1887, vol. 51, p. 553
[3] Chemische Berichte, 1884, vol. 17, p. 1998[4] Chemische Berichte, 1887, vol. 20, p. 2345 Anm.
  • 10
  • [ 131543-46-9 ]
  • [ 288-32-4 ]
  • [ 492-98-8 ]
Reference: [1] Zhurnal Russkago Fiziko-Khimicheskago Obshchestva, 1875, vol. 7, p. 254
[2] Chemische Berichte, 1876, vol. 9, p. 1544[3] Chemische Berichte, 1877, vol. 10, p. 1366
[4] Justus Liebigs Annalen der Chemie, 1858, vol. 107, p. 199
  • 11
  • [ 106536-97-4 ]
  • [ 492-98-8 ]
  • [ 106536-99-6 ]
Reference: [1] Synthesis, 1986, # 4, p. 336 - 337
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 492-98-8 ]

Imidazoles

Chemical Structure| 138799-95-8

[ 138799-95-8 ]

(1H-Imidazol-2-yl)methanamine hydrochloride

Similarity: 0.88

Chemical Structure| 124312-73-8

[ 124312-73-8 ]

(1-Methyl-1H-imidazol-2-yl)methanamine

Similarity: 0.81

Chemical Structure| 119165-68-3

[ 119165-68-3 ]

2-(1H-Imidazol-2-yl)pyrazine

Similarity: 0.72

Chemical Structure| 858513-10-7

[ 858513-10-7 ]

2-(2-Methyl-1H-imidazol-1-yl)ethanamine dihydrochloride

Similarity: 0.71

Chemical Structure| 1739-84-0

[ 1739-84-0 ]

1,2-Dimethyl-1H-imidazole

Similarity: 0.70